Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1970-3-6
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-2674
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
681-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4904428-Acute Disease,
pubmed-meshheading:4904428-Adolescent,
pubmed-meshheading:4904428-Adult,
pubmed-meshheading:4904428-Catatonia,
pubmed-meshheading:4904428-Clinical Trials as Topic,
pubmed-meshheading:4904428-Female,
pubmed-meshheading:4904428-Humans,
pubmed-meshheading:4904428-Schizophrenia,
pubmed-meshheading:4904428-Trifluoperazine
|
pubmed:articleTitle |
[Treatment with trifluoperazine (stelazine) in acute states of amential-catatonic schizophrenic psychoses].
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|